Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
Jingjing ChenHui XuZhangzhe PengLizhen LinCuifang LiXuejing ZhuManhua LiuPublished in: Clinical and experimental nephrology (2019)
CS protected the renal outcome and slowed the eGFR decline rate of IgAN patients with C1, it also decreased the eGFR decline rate even in those with initial proteinuria < 1 g/day.